Stock CYBERSPACE VITA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Cyberspace Vita Inc Stock Other OTC

Equities

US23254D3044

Pharmaceuticals

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Cyberspace Vita Inc
2021 Gsrx Industries Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
2021 GSRX Industries Inc. Announces Resignation of Aman Parmar as Member of the Board of Directors CI

Financials (USD)

Sales 2018 2.68 Sales 2019 11 Capitalization 1.34M
Net income 2018 -16M Net income 2019 -36M EV / Sales 2018 26,486,381 x
Net cash position 2018 1.31M Net Debt 2019 2.27M EV / Sales 2019 328,290 x
P/E ratio 2018
-4.29 x
P/E ratio 2019
-0.03 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 13.26%
More Fundamentals * Assessed data

Latest news about Cyberspace Vita Inc

Gsrx Industries Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
GSRX Industries Inc. Announces Resignation of Aman Parmar as Member of the Board of Directors CI
Department of Health of Puerto Rico Has Not Renewed Licenses Held by GSRX Industries Inc CI
Seneca Capital Partners, LP acquired 95% interest in Green Room Palm Springs, LLC from GSRX Industries Inc. for $0.4 million. CI
Gsrx Industries Inc. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
GSRX Industries Inc. Auditor Raises 'Going Concern' Doubt CI
Gsrx Industries Inc. Appoints Steven Farkas to Serve as A Director of the Corporation CI
GSRX Industries Inc. Announces Resignation of Mike Aujla as Member of the Board of Directors CI
GSRX Industries Inc. Announces Board Changes CI
GSRX Industries Inc. Announces Management Changes CI
Gsrx Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
GSRX Industries Inc Announces Resignation of Andrew Alvis as Chief Operating Officer CI
GSRX Industries Inc. Receives State-Wide Manufacturing and Distribution Licenses for its Facility in Point Arena, California CI
Cyberspace Vita, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
GSRX Industries Inc. Appoints Aman Parmar as Director CI
More news

Press releases Cyberspace Vita Inc

GSRX INDUSTRIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q) AQ
GSRX Industries Inc. Announces the Launch of Wrap Hack Cafe, a Virtual Delivery Only Restaurant NE
GSRX Industries Inc. Announces New Corporate Identity, Expansion of Business Verticals and Relocation of Corporate Headquarters NE
GSRX INDUSTRIES INC. : Change in Directors or Principal Officers (form 8-K) AQ
GSRX INDUSTRIES INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
More press releases

Managers and Directors - Cyberspace Vita Inc

Managers TitleAgeSince
Troy Nihart CEO
 Chief Executive Officer 46 20-03-09
Thomas J. Gingerich DFI
 Director of Finance/CFO 63 -
Members of the board TitleAgeSince
Troy Nihart CEO
 Chief Executive Officer 46 20-03-09
Jeff Rogers BRD
 Director/Board Member 61 20-03-09
Shaun Dale BRD
 Director/Board Member 47 20-04-22
More insiders

Company Profile

GSRX Industries Inc, through its subsidiaries, is in the business of acquiring, developing, and operating retail cannabis dispensaries and non-tetrahydrocannabinol (THC) cannabidiol (CBD) retail stores. The Company also is in the process of expanding its business to include distribution, extraction and light manufacturing, and delivery of cannabis and cannabinoid products. It operates five cannabis dispensaries in Puerto Rico under the name Green Spirit RX and one dispensary in California under the name The Green Room. The Company also owns and operates the e-commerce site GetPureAndNatural.com, which offers a broad range of hemp extract products.
Sector
Pharmaceuticals
More about the company

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.92% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.68% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.59% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.38% 322B
ABBVIE INC. Stock AbbVie Inc.
+9.39% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.30% 215B
NOVARTIS AG Stock Novartis AG
+4.80% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.05% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.58% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GSRX Stock
  4. Stock